WOBURN, MA / ACCESSWIRE / May 15, 2023 / Biofrontera Inc. (Nasdaq:BFRI) (the "Company"), a biopharmaceutical company specializing in the commercialization of dermatologic products, announces that the ...
Announcing a new publication for Acta Materia Medica journal. Treatment of cancer can be challenging, because of the disease’s intricate and varied nature. Consequently, developing nanomedicines with ...
Novel Protocol is Expected to be Less Painful with Efficacy Similar to Conventional PDT WOBURN, MA / ACCESSWIRE / May 15, 2023 / Biofrontera Inc. (Nasdaq:BFRI) (the "Company"), a biopharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback